Literature DB >> 35083544

A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity.

Jacopo Davide Giamello1, Giuseppe Lauria2, Andrea Antonuzzo3, Paolo Bossi4, Bartolomeo Lorenzati2, Gianmauro Numico5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35083544     DOI： 10.1007/s00520-022-06844-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.359


× No keyword cloud information.
  9 in total

1.  Cancer Patients in the Emergency Department: A "Nightmare" that Might Become a Virtuous Clinical Pathway.

Authors:  Jacopo Maria Legramante; Stefania Pellicori; Andrea Magrini; Tiziana Frittelli; Vincenzo Formica; Mario Roselli
Journal:  Anticancer Res       Date:  2018-11       Impact factor: 2.480

2.  Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center.

Authors:  Imad El Majzoub; Aiham Qdaisat; Kyaw Z Thein; Myint A Win; Myat M Han; Kalen Jacobson; Patrick S Chaftari; Michael Prejean; Cielito Reyes-Gibby; Sai-Ching J Yeung
Journal:  Ann Emerg Med       Date:  2018-06-05       Impact factor: 5.721

Review 3.  Immunotherapy Adverse Events: An Emergency Nursing Perspective.

Authors:  Enza Esposito Nguyen; Elizabeth Winokur
Journal:  J Emerg Nurs       Date:  2019-08-08       Impact factor: 1.836

Review 4.  A Systematic Review of Emergency Department Use Among Cancer Patients.

Authors:  Rebecca S Lash; Janice F Bell; Sarah C Reed; Hermine Poghosyan; James Rodgers; Katherine K Kim; Richard J Bold; Jill G Joseph
Journal:  Cancer Nurs       Date:  2017 Mar/Apr       Impact factor: 2.592

5.  Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.

Authors:  Olivier Peyrony; Yoann Tieghem; Jessica Franchitti; Sami Ellouze; Ivonne Morra; Isabelle Madelaine-Chambrin; Remi Flicoteaux; Barouyr Baroudjian; Elie Azoulay; Sylvie Chevret; Jean-Paul Fontaine
Journal:  Emerg Med J       Date:  2019-03-25       Impact factor: 2.740

6.  Clinical Characteristics of Patients with Cancer Presenting to the Emergency Department and Their Use of Emergency Medical Service Transport.

Authors:  Baibing Chen; Christopher Kanaan; Ishmael Jaiyesimi; Daniel Ezekwudo; Robert Swor
Journal:  Prehosp Emerg Care       Date:  2020-02-25       Impact factor: 3.077

Review 7.  A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.

Authors:  Neeraj Chhabra; Joseph Kennedy
Journal:  J Med Toxicol       Date:  2021-04-07

8.  Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors.

Authors:  Deniz Can Guven; Taha Koray Sahin; Melek Seren Aksun; Hakan Taban; Oktay Halit Aktepe; Nalan Metin Aksu; Meltem Akkaş; Mustafa Erman; Saadettin Kilickap; Omer Dizdar; Sercan Aksoy
Journal:  Support Care Cancer       Date:  2020-08-26       Impact factor: 3.603

9.  Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.

Authors:  Alyson Haslam; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2019-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.